Haiyan Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 7
- Carcinogens and Genotoxicity Assessment 3
- Co-authors
- Jun Chen (1 shared paper)Miao Sui (1 shared paper)Xiaofei Jiang (1 shared paper)Johan G. de Boer (4 shared papers)Zhaohui Lu (4 shared papers)Jie Chen (3 shared papers)Barry W. Glickman (3 shared papers)Jing Zhang (2 shared papers)
- Journals
- Journal of Pharmacy and Pharmacology (2 papers)Scientific Reports (2 papers)Nutrition and Cancer (2 papers)Frontiers in Aging Neuroscience (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Haiyan Yang
31 papers receiving 606 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 300
- Molecular Biology 381
- Biomaterials 58
- Hepatology 31
- Pulmonary and Respiratory Medicine 125
Countries citing papers authored by Haiyan Yang
This map shows the geographic impact of Haiyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Yang more than expected).
Fields of papers citing papers by Haiyan Yang
This network shows the impact of papers produced by Haiyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Yang. The network helps show where Haiyan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Haiyan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 129 | |
| 2 | 2017 | 63 | |
| 3 | 2019 | 55 | |
| 4 | 2015 | 46 | |
| 5 | 2008 | 35 | |
| 6 | 2008 | 31 | |
| 7 | 2004 | 26 | |
| 8 | 2010 | 21 | |
| 9 | 2001 | 21 | |
| 10 | 2015 | 19 | |
| 11 | 2017 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2002 | 16 | |
| 14 | 2008 | 16 | |
| 15 | 2022 | 13 | |
| 16 | 2002 | 11 | |
| 17 | 2016 | 11 | |
| 18 | Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma. | 2009 | 10 |
| 19 | 2012 | 10 | |
| 20 | 2024 | 7 |
About Haiyan Yang
Haiyan Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 31 papers that have together received 614 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Circular RNAs in diseases (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Thyroid Disorders and Treatments (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Cancer Research (300 citations), Molecular Biology (381 citations), Biomaterials (58 citations), Hepatology (31 citations) and Pulmonary and Respiratory Medicine (125 citations). Haiyan Yang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jun Chen, Miao Sui, Xiaofei Jiang, Johan G. de Boer, Zhaohui Lu, Jie Chen, Barry W. Glickman, Jing Zhang, Caixia Wang and Shuangni Yu. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Scientific Reports, Nutrition and Cancer, Frontiers in Aging Neuroscience and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.